Skip to main content
. 2018 Feb 1;2018(2):CD004879. doi: 10.1002/14651858.CD004879.pub5

Comparison 2. Inactivated vaccine versus placebo (RCTs).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Influenza 5 1628 Risk Ratio (M‐H, Random, 95% CI) 0.36 [0.28, 0.48]
2 Influenza‐like illness 4 19044 Risk Ratio (M‐H, Random, 95% CI) 0.72 [0.65, 0.79]
2.1 Inactivated vaccines (1 dose) 2 267 Risk Ratio (M‐H, Random, 95% CI) 0.35 [0.15, 0.81]
2.2 Inactivated vaccines (2 doses) 2 18777 Risk Ratio (M‐H, Random, 95% CI) 0.72 [0.69, 0.76]
3 Acute otitis media 3 884 Risk Ratio (M‐H, Random, 95% CI) 1.15 [0.95, 1.40]
3.1 Inactivated vaccines (1 dose) 1 136 Risk Ratio (M‐H, Random, 95% CI) 1.52 [0.10, 23.76]
3.2 Inactivated vaccines (2 doses) 2 748 Risk Ratio (M‐H, Random, 95% CI) 1.15 [0.95, 1.40]
4 School absenteeism 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
5 Influenza‐like illness (clustering sensitivity analysis) 4 6126 Risk Ratio (M‐H, Random, 95% CI) 0.70 [0.60, 0.82]
5.1 Inactivated vaccines (1 dose) 2 267 Risk Ratio (M‐H, Random, 95% CI) 0.35 [0.15, 0.81]
5.2 Inactivated vaccines (2 doses) 2 5859 Risk Ratio (M‐H, Random, 95% CI) 0.72 [0.66, 0.79]